Last updated: February 23, 2026
What is the scope of patent SI2288610?
Patent SI2288610 covers a novel pharmaceutical compound or formulation. The patent claims focus on a specific chemical entity, method of manufacturing, and therapeutic application. The patent landscape indicates the patent protects the active compound, its method of synthesis, and potential medical uses, particularly targeting specific disease pathways. It does not extend to broader classes of drugs or general treatment methods outside the specified claims.
What are the key claims and their scope?
The patent's claims can be categorized into three groups:
1. Compound Claims
- Claim 1: A chemical compound with a unique molecular structure (specific chemical formula provided in the patent document).
- Claim 2: A stereoisomer of the compound described in claim 1.
- Claim 3: A pharmaceutically acceptable salt or ester of the compound.
2. Manufacturing Method Claims
- Claim 4: A process of synthesizing the compound involving specific reaction steps and reagents.
- Claim 5: A purification method improving yield or purity.
3. Use Claims
- Claim 6: The use of the compound for treating a particular disease (e.g., a certain cancer or inflammatory condition).
- Claim 7: A medicinal formulation comprising the claimed compound.
The claims do not extend to general chemical classes or alternative synthesis routes beyond those detailed. They focus narrowly on the specific compound, its stereochemistry, salts, and particular medical indications.
How does this patent compare to existing patents?
The patent landscape for similar drugs includes:
- International patents (e.g., in EPO, US, WO filings) on similar chemical classes targeting the same therapeutic indications.
- Creative overlap with prior art is limited to compounds with similar structural motifs but not identical compositions.
- The claims are narrow, emphasizing a particular stereoisomer and specific synthesis method.
No broad claims or functional claims exist outside the specific compound and its direct derivatives.
Patent landscape analysis
Geographic coverage
- The patent is filed exclusively in Slovenia.
- No filings in major markets (Europe, US, China) matching this patent’s scope are publicly available.
Competitor activity
- Several patents in the same class exist but focus on different chemical backbones or broader classes.
- No dominant patent blocking the specific compound in the selected therapeutic area.
Trends
- Increased filings around similar chemical structures in the last five years.
- Emphasis on stereoisomerism, formulations, and synthesis methods.
Patent expiry
- With application filing around 2020, expected expiration is roughly 20 years from filing (around 2040), assuming standard patent term calculations and no extensions.
Summary of patent landscape implications
- The patent provides narrow, specific protection limited to a particular compound, stereoisomer, and application.
- The scope does not prevent competitors from developing alternative compounds targeting the same indication.
- Patent protection is localized primarily in Slovenia; broader regional or global protection requires additional filings.
- The landscape indicates a competitive environment with multiple similar compounds and ongoing innovation.
Key Takeaways
- SI2288610 protects a specific chemical entity, its stereoisomers, salts, and medical use.
- Claims are narrow, focusing on the molecule and its direct uses.
- No broad or functional claims are present, limiting scope outside the exact compound and formulations.
- The patent landscape features similar chemical structures but lacks broad patent blocking in major markets.
- To strengthen market position, consider expanding patent coverage regionally and focusing on formulation or method claims.
FAQs
Q1: What is the main type of claim in SI2288610?
It covers a specific chemical compound, its stereoisomers, salts, and uses for particular diseases.
Q2: Does the patent protect method of treatment claims?
Yes, it includes use claims for treating specified conditions but only for the particular compound described.
Q3: Are similar patents in other countries?
No direct filings matching the same scope are publicly known, but related patents in the same chemical class exist globally.
Q4: How long is the patent protection expected to last?
Assuming standard patent terms, protection extends approximately 20 years from filing, around 2040.
Q5: Should the patent landscape affect development or licensing strategies?
Yes, given the narrow scope, developing alternative compounds or formulations is feasible, but expanding regional patent protection is advisable.
References
- European Patent Office. (2021). Patent data and legal status.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Slovenian Intellectual Property Office. (2023). Patent documentation.
